These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)]. Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350 [No Abstract] [Full Text] [Related]
24. [The effect of oral prazosin therapy on severe cardiac insufficiency]. Józan M; Tarján J; Tordasi E; Wágner G; Bordás I; Jávor A; Kovács S Orv Hetil; 1983 May; 124(21):1259-61. PubMed ID: 6877803 [No Abstract] [Full Text] [Related]
25. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure. Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894 [TBL] [Abstract][Full Text] [Related]
26. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126 [TBL] [Abstract][Full Text] [Related]
27. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system. Yui Y; Sakurai T; Nakajima H; Kawai C Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282 [TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of prazosin in chronic congestive heart failure]. Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769 [No Abstract] [Full Text] [Related]
29. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Packer M; Meller J; Gorlin R; Herman MV Circulation; 1979 Mar; 59(3):531-9. PubMed ID: 761333 [No Abstract] [Full Text] [Related]
30. Attenuation of prazosin effect on cardiac output in chronic heart failure. Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164 [TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis. Greenberg BH; Massie BM Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134 [No Abstract] [Full Text] [Related]
32. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434 [No Abstract] [Full Text] [Related]
33. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure. Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686 [TBL] [Abstract][Full Text] [Related]
34. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)]. Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740 [No Abstract] [Full Text] [Related]
35. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure. Lui HK; Awan NA; Mason DT Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929 [No Abstract] [Full Text] [Related]
36. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]